Novartis Atopic Dermatitis Drug Elidel Launch Projected For 2002
Executive Summary
Novartis is planning a U.S. launch for its atopic dermatitis cream Elidel in 2002 following an NDA filing on Dec. 15.
You may also be interested in...
Novartis To File Elidel sNDA For Younger Age Group After Approval
Novartis plans to file a supplemental NDA for Elidel in patients as young as three months following FDA's Dec. 13 approval of the atopic dermatitis cream in patients older than two years
Novartis To File Elidel sNDA For Younger Age Group After Approval
Novartis plans to file a supplemental NDA for Elidel in patients as young as three months following FDA's Dec. 13 approval of the atopic dermatitis cream in patients older than two years
Pharmacia Could See Double COX-2 NME Drug Approvals In 2001
Pharmacia could gain approval of two COX-2 inhibitor drugs that are new molecular entities by late 2001.